Delivery Order SPE2DB20D1100-SPE2DB24FD1V5

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,926.10 Firm Fixed Price Delivery Order is for the supply of 4564981329 GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
This federal contract award, valued at $1,961.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Granix 480 mcg Tbo. This contract is not set aside and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,096,500 units of the pharmaceutical product GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML. The contract has a firm fixed price of $8,824.41 and a completion date of July 10, 2024. This is a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. The contract is a Firm Fixed Price Delivery Order valued at $7,214.20 and has an ultimate completion date of August 2, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
The Defense Logistics Agency awarded a $2,960.97 delivery order to Amerisourcebergen Drug Corporation for 4561633870 GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. The firm fixed price order is for product delivery from Amerisourcebergen's Conshohocken, Pennsylvania facility. Performance will occur between July 28 and July 31, 2023 to supply the pharmaceutical item in support of DLA programs. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the United...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of granisetron HCL 1 mg tablets. The $3,064.09 firm fixed price delivery order is not associated with a set-aside program and has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,121.86 firm fixed-price contract has a completion date of February 18, 2025 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,392.90 firm fixed-price contract has a completion date of February 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,785.10 firm-fixed-price contract has a completion date of January 31, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a division of Cencora, Inc. The $1,791.95 firm-fixed-price contract is for the supply of pharmaceutical products and medical supplies to support the U.S. government's medical needs. The award has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous delivery orders against an Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD1V5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,888.51 firm fixed-price contract is for the delivery of Granix 300 mcg syringes, a specialty medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities. This particular award is not designated as a set-aside contract.

Generated 11/7/24, 9:37 AM